Real-time tracking of pharmaceutical manufacturing volume would go a long way toward helping the US Food and Drug Administration better anticipate drug shortages and drug-related national security risks, Janet Woodcock, director of the agency’s Center for Drug Evaluation and Research, told Congress 30 October.
However, such tracking would require legislation, she told a House Energy and Commerce Health Subcommittee hearing, because as it stands now, “We don't have the